ECSP15009978A - GLUCAGON ANALOGUES - Google Patents
GLUCAGON ANALOGUESInfo
- Publication number
- ECSP15009978A ECSP15009978A ECIEPI20159978A ECPI201509978A ECSP15009978A EC SP15009978 A ECSP15009978 A EC SP15009978A EC IEPI20159978 A ECIEPI20159978 A EC IEPI20159978A EC PI201509978 A ECPI201509978 A EC PI201509978A EC SP15009978 A ECSP15009978 A EC SP15009978A
- Authority
- EC
- Ecuador
- Prior art keywords
- methods
- glucagon analogues
- glucagon
- peptides
- glp
- Prior art date
Links
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical class C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000007446 Glucagon-Like Peptide-1 Receptor Human genes 0.000 abstract 1
- 108010086246 Glucagon-Like Peptide-1 Receptor Proteins 0.000 abstract 1
- 101500028775 Homo sapiens Glucagon Proteins 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención proporciona materiales y procedimientos para el tratamiento de obesidad y exceso de peso, diabetes y otros trastornos metabólicos asociados. En particular, la invención proporciona péptidos análogos de glucagón novedosos eficaces en dichos procedimientos. Los péptidos pueden mediar su efecto al tener una selectividad aumentada por el receptor de GLP-1 en comparación con el glucagón humano.The invention provides materials and methods for the treatment of obesity and excess weight, diabetes and other associated metabolic disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. Peptides may mediate their effect by having increased selectivity for the GLP-1 receptor compared to human glucagon.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261701952P | 2012-09-17 | 2012-09-17 | |
| EP12184744 | 2012-09-17 | ||
| US201361784294P | 2013-03-14 | 2013-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP15009978A true ECSP15009978A (en) | 2015-12-31 |
Family
ID=69400750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI20159978A ECSP15009978A (en) | 2012-09-17 | 2015-03-16 | GLUCAGON ANALOGUES |
Country Status (3)
| Country | Link |
|---|---|
| DK (1) | DK2895505T3 (en) |
| EC (1) | ECSP15009978A (en) |
| ES (1) | ES2768601T3 (en) |
-
2013
- 2013-09-17 ES ES13765701T patent/ES2768601T3/en active Active
- 2013-09-17 DK DK13765701.1T patent/DK2895505T3/en active
-
2015
- 2015-03-16 EC ECIEPI20159978A patent/ECSP15009978A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2768601T3 (en) | 2020-06-23 |
| DK2895505T3 (en) | 2020-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO7400885A2 (en) | Glucagon analogues | |
| MX2016004461A (en) | Acylated glucagon analogues. | |
| ECSP12011593A (en) | GLUCAGON ANALOGS ACCILATED | |
| MX2016004907A (en) | Glucagon analogues. | |
| ECSP12012351A (en) | GLUCAGON ANALOGS | |
| CO6660483A2 (en) | Glucagon analogues | |
| MX372841B (en) | ACYLATED ANALOGUE OF GLUCAGON. | |
| CL2014003421A1 (en) | Glucagon analogs exhibiting agonist activity at the glusose-dependent insulinotropic peptide receptor (gip): pharmaceutical composition; and method to reduce weight gain or induce weight loss, particularly for the treatment of obesity. | |
| UY34859A (en) | Peptide analogs of exendin 4. | |
| BR112013032717A2 (en) | glucagon / glp-1 receptor coagonists | |
| MX2019006260A (en) | GLUCAGON AGONISTS / GLUCAGON-LIKE PEPTIDE 1 (GLP-1) FOR THE TREATMENT OF OBESITY. | |
| UY36779A (en) | NEW DERIVATIVES OF EXENDINA-4 AS SPECIFIC DUAL PEPTIDE AGONISTS OF GLP-1 / GLUCAGÓN RECEPTORS | |
| UY35548A (en) | THERAPEUTIC PEPTIDES FOR THE TREATMENT OF METABOLIC DISORDERS. | |
| ECSP15009978A (en) | GLUCAGON ANALOGUES | |
| CO6382136A2 (en) | GLUCAGON ANALOGS | |
| TN2011000667A1 (en) | Acylated glucagon analogues | |
| TH169484A (en) | Acetylated analog glucagon |